Variable | Lidocaine (N = 35) | PRP (N = 36) | ||
---|---|---|---|---|
Age, n, M ± SD | 35 | 48.26 ± 7.64 | 36 | 50.80 ± 6.73 |
Gender, no. (%) | ||||
 Male | 19 | (54.3) | 14 | (38.9) |
 Female | 16 | (45.7) | 22 | (61.1) |
Manual worker, no. (%) | ||||
 No | 10 | (29.4) | 11 | (28.2) |
 Yes | 24 | (70.6) | 25 | (71.8) |
Throwing sports, no. (%) | ||||
 No | 29 | (87.9) | 33 | (94.3) |
 Yes | 4 | (12.1) | 2 | (5.7) |
Other sports, no. (%) | ||||
 No | 20 | (60.6) | 22 | (62.9) |
 Yes | 13 | (39.4) | 13 | (37.1) |
BMI, n, M ± SD | 34 | 26.05 ± 3.15 | 36 | 25.58 ± 4.19 |
Hypercholesterolemia, no. (%) | ||||
 No | 29 | (82.9) | 34 | (94.4) |
 Yes | 6 | (17.1) | 2 | (5.6) |
Hypercholesterolemia treatment | ||||
 No | 31 | (88.6) | 35 | (97.2) |
 Yes | 4 | (11.4) | 1 | (2.8) |
Diabetes, no. (%) | ||||
 No | 34 | (97.1) | 36 | (100.0) |
 Yes | 1 | (2.9) | 0 | (0.0) |
Diabetes treatment | ||||
 No | 34 | (97.1) | 36 | (100.0) |
 Yes | 1 | (2.6) | 0 | (0.0) |
Hyperuricaemia, no. (%) | ||||
 No | 35 | (100.0) | 36 | (100.0) |
Tendon involvement, no. (%) | ||||
 Lateral | 31 | (88.6) | 29 | (80.6) |
 Medial | 4 | (11.4) | 7 | (19.4) |
Location, no. (%) | ||||
 Left | 9 | (25.7) | 15 | 41.7 |
 Right | 26 | (74.3) | 21 | 58.3 |
Neovascularization, no. (%) | ||||
 No neovascularization | 7 | (20.0) | 6 | (16.7) |
 Neovessels on the tendon surface | 2 | (5.7) | 3 | (8.3) |
 Intratendinous neovessels | 26 | (74.3) | 27 | (75.0) |
Echotexture grading scale, no. (%) | ||||
 Normal | 3 | (8.6) | 1 | (2.8) |
 Hypoechogenicity < 1/3 of the tendon | 2 | (5.7) | 4 | (11.1) |
 Hypoechogenicity > 1/3 and < 2/3 | 10 | (28.6) | 11 | (30.6) |
 Hypoechogenicity > 2/3 | 15 | (42.9) | 17 | (47.2) |
 Partial-thickness tear | 5 | (14.3) | 3 | (8.3) |
Calcifications, no. (%) | ||||
 No | 28 | (80.0) | 32 | (91.4) |
 Yes | 7 | (20.0) | 3 | (8.6) |
Tendon thickness, n, M ± SD | 35 | 1.16 ± 0.21 | 36 | 1.17 ± 0.21 |
DASH-E, n, M ± SD | 33 | 44.06 ± 14.05 | 36 | 44.74 ± 17.09 |
VAS-P, n, M ± SD | 35 | 5.87 ± 1.52 | 35 | 5.91 ± 1.78 |